Gilead Sciences (GILD) Gains from Investment Securities (2013 - 2015)

Gilead Sciences (GILD) has reported Gains from Investment Securities for 3 consecutive years, with $2.0 million the latest figure, recorded in Q1 2015.

• For the quarter ending Q1 2015, Gains from Investment Securities fell 33.33% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2015 stood at $21.0 million (down 62.48% YoY), and the FY2014 full-year result was $22.0 million, down 62.71% from the prior year.
• Gains from Investment Securities fell to $2.0 million in Q1 2015 per GILD's latest filing, from $26.1 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $30.0 million in Q3 2013 and bottomed at -$12.1 million in Q3 2014.
• Historically, Gains from Investment Securities has averaged $9.2 million across 3 years, with a median of $6.0 million in 2013.
• The widest YoY moves for Gains from Investment Securities: up 125.98% in 2014, down 140.28% in 2014.
• Over 3 years, Gains from Investment Securities stood at $11.6 million in 2013, then surged by 125.98% to $26.1 million in 2014, then sank by 92.34% to $2.0 million in 2015.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $2.0 million, $26.1 million, and -$12.1 million for Q1 2015, Q4 2014, and Q3 2014 respectively.